optimalisering av brystkreftbehandling
- Prosjektnummer
- 46019100
- Ansvarlig person
- Ingrid S. Gribbestad
- Institusjon
- NTNU, ISB
- Prosjektkategori
- Flerårig prosjekt 2007
- Helsekategori
- Cancer
- Forskningsaktivitet
- 4. Detection and Diagnosis
Triple-negative breast cancer: present challenges and new perspectives.
Mol Oncol 2010 Jun;4(3):209-29. Epub 2010 apr 24
PMID: 20537966
Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis.
Acta Radiol 2010 Jul;51(6):604-12.
PMID: 20429756
Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.
NMR Biomed 2010 May;23(4):424-31. Epub 2010 jan 25
PMID: 20101607
Short echo time 1H MRSI of the human brain at 3T with adiabatic slice-selective refocusing pulses; reproducibility and variance in a dual center setting.
J Magn Reson Imaging 2010 Jan;31(1):61-70.
PMID: 20027568
Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics.
J Proteome Res 2010 Feb;9(2):972-9.
PMID: 19994911
Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.
NMR Biomed 2010 Jan;23(1):56-65.
PMID: 19650073
Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE-MRI.
J Magn Reson Imaging 2009 Jun;29(6):1300-7.
PMID: 19472387
MR determind metabolites may serve as prognostic factors in breast cancer.
ISMRM 2010; 2010-05-02 - 2010-05-07
A new harvesting method to provide high quality prostate cancer tissue suitable for 1H HR MAS MR spectroscopy and gene expressio
ISMRM; 2010-05-01 - 2010-05-04
Predicting long-term breast cancer survival in patients receiving neoadjuvant chemotherapy by MR metabolic profiling.
MI Lab day; 2010-04-29
Predicting long-term survival for breast cancer patients by HR MAS metabolic profiling during neoadjuvant chemotherapy.
ISMRM 2010; 2010-05-01 - 2010-05-07
Peak alignment of MR spectra.
ISMRM 2010; 2010-05-02 - 2010-05-07
Functional and molecular MR for breast cancer characterization.
European Association for Cancer Research (EACR) 2010; 2010-06-26 - 2010-06-29
How to perform HR MAS studies in tissue.
ISMRM 2010; 2010-05-02 - 2010-05-07
HR MAS MR spectroscopy of intact cancer tissue samples.
The CRI symposium: Unanswered Questions in Tumour Monitoring; 2010-03-15
HR MAS MRS of biopsy samples.
Sahlgrensa University Hospital; 2010-03-01
MR av kreft – fra molekyl til pasient.
Fagdagene; 2010-06-10 - 2010-06-11
13C HR MAS MRS reveals differences in the glucose metabolism between two breast cancer xenograft models with different gene expr
International Society of Magnetic Resonance in Medicine (ISMRM); 2010-05-01 - 2010-05-07
13C HR-MAS MRS reveals differences in glucose metabolism between two breast cancer xenograft models with different gene expressi
FUGE-seminar, Workshop: Karakterisering av brystkreft; 2010-09-01
Assessment of tumor microenvironment and treatment effects in human breast cancer xenografts using MR imaging and spectroscopy.
Trondheim: NTNU 2010 (ISBN 978-82-471-2455-0) 170 s.
Dynamic contrast-enhanced magnetic resonance imaging reveals differences in xenografts with luminal like and basal like gene exp
ISMRM Scientific Workshop; 2010-05-01 - 2010-05-07
In vivo magnetic resonance imaging and histopathological assessment of tumor microenvironment in luminal-like and basal-like bre
FUGE Meeting; 2010-09-01 - 2010-09-03
Diffusion weighted and dynamic contrast enhanced MRI in evaluation of treatment effects during neoadjuvant chemotherapy.
International Society of Magnetic Resonance in Medicine; 2010-05-01 - 2010-05-07
Evaluation of treatment effects in cancer by MR imoging and spectroscopy.
Trondheim: Norges teknisk-naturvitenskapelige universitet 2010 (ISBN 978-82-471-2012-5)
Choline metabolism in basal-like and luminal-like breast cancer xenografts respond differently to doxorubicin and bevacizumab tr
ISMRM; 2010-05-01 - 2010-05-09
MR spectroscopy of breast cancer patients for prediction of treatment response – combining in vivo and ex vivo analysis.
ISMRM (18th Scientific Meeting in the International Society of Magnetic Resonance in Medicine); 2010-05-01 - 2010-05-07
In vivo and ex vivo MR approaches for studies of cancer.
Avd. for ernæringsvitenskap, Institutt for medisinske basalfag, UiO; 2010-06-09 - 2010-06-09
High resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer (review).
Prog Nucl Magn Reson Spectrosc 2009; 54: 239-254
metabolomics - et spennende verktøy i medisinsk og biologisk forskning.
NBS-nytt 2009 ;Volum 1. s. 10-15
High-resolution MAS MRS of breast cancer biopsies - different approaches.
European Radiology 2009 ;Volum 19. Suppl. 4 s. s822-s826
Is there a correlation between DCE-MRI and survival?.
European Radiology 2009 ;Volum 19. Suppl. 4 s. s826-s829
MR metabolomics – a tool in detection of biomarkers for response to neoadjuvant chemotherapy in local advanced breast cancer?.
ESMRMB 2009 Annual Congress;Turkey. Conference proceedings
Choline metabolites as biomarkers for predicting response to neoadjuvant chemotherapy in local advanced breast cancer patients.
ISMRM Congress; 2009, Hawaii. Conference proceedings
Classification and prediction of prognostic factors of breast cancer patients by MR metabolomics.
ISMRM Congress; 2009, Hawaii. Conference proceedings
HR MAS 13C MRS characterization of two breast cancer xenograft models.
ISMRM Congress; 2009, Hawaii. Conference proceedings
In vivo and ex vivo choline metabolite profiles as biomarkers for treatment response in locally advanced breast cancer
ISMRM Congress; 2009, Hawaii. Conference proceedings
Multiparametric MRI/MRS and gene expression profiling for monitoring docetaxel effects in MCF7 xenografts.
ISMRM Congress; 2009, Hawaii. Conference proceedings
Dynamic contrast-enhanced magnetic resonance imaging reveals differences in xenografts with luminal like and basal like gene exp
ESMRMB 2009 Annual Congress;Turkey. Conference proceedings
Diffusion measurements in advanced breast cancer – reproducibility and changes after treatment.
ESMRMB 2009 Annual Congress;Turkey. Conference proceedings
Evaluation of vascular and metabolic response in a human breast cancer model treated with docetaxel.
ISMRM Congress; 2009, Hawaii. Conference proceedings
Choline metabolic composition correlates to basal-like and luminal A genetic subtypes in orthotopic breast cancer xenografts.
ISMRM Congress; 2009, Hawaii. Conference proceedings
Tissue metabolic concentrations investigated with respect to prognosis for breast cancer patients
ISMRM Congress; 2009, Hawaii. Conference proceedings
Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in viv
NMR Biomed , e-publ (Publmed) 2009
Multivariate Modeling and Prediction of Breast Cancer Prognostic Factors Using MR Metabolomics.
J Proteome Res Epub 2009
Short echo time 1H MRSI of the human brain at 3T with adiabatic slice-selective refocusing pulses; reproducibility and variance
J Magn Reson Imaging E-publ 2009
Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.
NMR Biomed Epub 2009
Evaluation of treatment effects in cancer by MR imoging and spectroscopy.
- Disputert:
- mars 2010
- Hovedveileder:
- Ingrid S. Gribbestad
Assessment of tumor microenvironment and treatment effects in human breast cancer xenografts using MR imaging and spectroscopy.
- Disputert:
- november 2010
- Hovedveileder:
- Ingrid S. Gribbestad
MR evaluation of Breast Cancer Patients with a Poos Prognosis
- Disputert:
- oktober 2010
- Hovedveileder:
- Steinar Lundgren
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Helse Midt-Norge RHF - Samarbeidsorganet og FFU